ILD medications: pirfenidone

ILD_PIRFENIDONE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AX05

211

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

187

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

187

diagram downward connector

Include endpoints None

187

diagram downward connector
ILD_PIRFENIDONE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 187 49 138
Unadjusted prevalence (%) 0.05 0.02 0.09
Mean age at first event (years) 69.99 70.40 69.84

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_PIRFENIDONE – ILD medications: pirfenidone
GWS hits:

Survival analyses between endpoints

Plot

before ILD medications: pirfenidone
after ILD medications: pirfenidone

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: pirfenidone